Company · CIK 0001437402 · SIC 2834 — Pharmaceutical Preparations · Nasdaq

ARDELYX, INC. · ARDX

Insider activity reported against this company. All insider holders · On EDGAR ↗

Period1M 3M 6M 1Y 2Y All datashares as filed — not split-adjusted

Open-market buys & salesbuys $0 · 0sales $697k · 9net −$697k

Reported at this company — common stock

Trade	Reported (ET)	Insider	Shares	Avg price	Total	Owned after	Δ stake	Flags
Aug 21, 2026 SForm 4 →	Aug 25, 7:19 pm EDT	Susan HohenleitnerChief Financial Officer	1,558	$3.86	$6,009	227,520	−0.68%
Aug 21, 2026 SForm 4 →	Aug 25, 7:17 pm EDT	Joseph James ReillySee Remarks	3,982	$3.86	$15,358	145,854	−2.66%
Aug 21, 2026 SForm 4 →	Aug 25, 7:16 pm EDT	John E BishopSee Remarks	19,750	$3.86	$76,174	317,095	−5.86%
Aug 21, 2026 SForm 4 →	Aug 25, 7:15 pm EDT	James Parker BradyChief Human Resources Officer	15,136	$3.86	$58,378	245,930	−5.80%
Aug 21, 2026 SForm 4 →	Aug 25, 7:13 pm EDT	Eric Duane FosterChief Commercial Officer	8,562	$3.86	$33,023	409,410	−2.05%
Aug 21, 2026 SForm 4 →	Aug 25, 7:11 pm EDT	Mike KelliherChief Business Officer	7,758	$3.86	$29,922	349,660	−2.17%
Aug 21, 2026 SForm 4 →	Aug 25, 7:09 pm EDT	Laura A WilliamsChief Patient Officer	10,739	$3.86	$41,419	367,456	−2.84%
Aug 21, 2026 SForm 4 →	Aug 25, 7:07 pm EDT	Michael RaabPresident & CEO, Director	58,574	$3.86	$225,914	1,619,792	−3.49%
Jul 15, 2026 SForm 4 →	Jul 17, 4:09 pm EDT	Michael RaabPresident & CEO, Director	41,668	$5.06	$210,923	1,678,366	−2.42%	10b5-1
Jul 15, 2026 MForm 4 →	Jul 17, 4:09 pm EDT	Michael RaabPresident & CEO, Director	20,834	$0.99	$20,626	1,720,034	—	10b5-1

Trade	Reported (ET)	Insider	Shares	Avg price	Total	Owned after	Δ stake	Flags
Jul 15, 2026 MForm 4 →	Jul 17, 4:09 pm EDT	Michael RaabPresident & CEO, Director	20,834	—	—	290,834	—	10b5-1